{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:45:11Z","timestamp":1790700311416,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11934-022-01098-6","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T04:02:46Z","timestamp":1654747366000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Use of Neutrophil Gelatinase\u2013Associated Lipocalin (NGAL) as a Diagnostic and Prognostic Biomarker in Urinary Tract Obstruction: a Systematic Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Anna","family":"Brewin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheshadri","family":"Sriprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6248-6478","authenticated-orcid":false,"given":"Bhaskar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"1098_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","volume":"48","author":"VS Vaidya","year":"2008","unstructured":"Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463\u201393. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094615.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1098_CR2","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Devarajan P. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury. Nephrol Dial Transplant. 2008;23(12):3737\u201343. https:\/\/doi.org\/10.1093\/ndt\/gfn531. A thorough synopsis of the current role of NGAL and its promising future as a predictive biomarker for AKI. It highlights its limitations in the presence of coexisting conditions.","DOI":"10.1093\/ndt\/gfn531"},{"issue":"4","key":"1098_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1399-3046.2007.00704.x","volume":"11","author":"JM Smith","year":"2007","unstructured":"Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA. Contributions of the transplant registry: the 2006 annual report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant. 2007;11(4):366\u201373. https:\/\/doi.org\/10.1111\/j.1399-3046.2007.00704.x.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"1098_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ki.2008.126","volume":"74","author":"JW Dear","year":"2008","unstructured":"Dear JW, Yuen PS. Setting the stage for acute-on-chronic kidney injury. Kidney Int. 2008;74(1):7\u20139. https:\/\/doi.org\/10.1038\/ki.2008.126.","journal-title":"Kidney Int"},{"key":"1098_CR5","doi-asserted-by":"publisher","unstructured":"\u2022 Bolgeri M, Whiting D, Reche A, Manghat P, Sriprasad S. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker of renal injury in patients with ureteric stones: a pilot study. Journal of Clinical Urology. 2021;14(1):21\u20138. https:\/\/doi.org\/10.1177\/2051415820947561. The only UK-based study which is most likely to mirror our current UK practice of managing acute ureteric colic and thus the role of NGAL in this population.","DOI":"10.1177\/2051415820947561"},{"key":"1098_CR6","doi-asserted-by":"publisher","DOI":"10.1159\/000517883","author":"Y G\u00f6ger","year":"2021","unstructured":"G\u00f6ger YE, \u00d6zkent MS, Top\u00e7u C, At\u0131c\u0131 A, S\u00f6nmez MG, Balasar M, G\u00fcrbilek M. Can urinary KIM-1 and NGAL predict management endoscopic surgery in acute unilateral obstructive stone disease? Results from a prospective cohort study. Urol Int. 2021. https:\/\/doi.org\/10.1159\/000517883.","journal-title":"Urol Int"},{"issue":"Supplement 1","key":"1098_CR7","doi-asserted-by":"publisher","first-page":"i22","DOI":"10.1093\/ndt\/gft152","volume":"28","author":"A Kretschmer","year":"2013","unstructured":"Kretschmer A, Kukuk S, Brandt AS, Burkhardt-Soares S, Bruck H, Roth S. Circulating biomarker profile characterizes patients with retroperitoneal fibrosis and concomitant ureter obstruction - An epidemiological study. Nephrol Dial Transplant. 2013;28(Supplement 1):i22\u20134. https:\/\/doi.org\/10.1093\/ndt\/gft152.","journal-title":"Nephrol Dial Transplant"},{"key":"1098_CR8","doi-asserted-by":"publisher","unstructured":"\u2022 Miranda EP, Duarte RJ, de Bessa J Jr, Lopes RI, Srougi V, Andrade HS, Bandeira RAST, Arap MA, Mitre AI, Viana NI, Reis ST, Leite KRM, Srougi M. The role of urinary KIM-1, NGAL, CA19\u20139 and \u03b22-microglobulin in the assessment of ureteropelvic junction obstruction in adults. Biomarkers. 2017;22(7):682\u201388. https:\/\/doi.org\/10.1080\/1354750X.2017.1284264. This study provided the most comprehensive follow-up of urinary NGAL levels from pre-pyeloplasty to 1-, 3-, and 6-month post-op. Able to assess the long-term trend of NGAL levels following resolution of urinary tract obstruction.","DOI":"10.1080\/1354750X.2017.1284264"},{"issue":"2","key":"1098_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/end.2016.0215","volume":"31","author":"D Olvera-Posada","year":"2017","unstructured":"Olvera-Posada D, Dayarathna T, Dion M, Alenezi H, Sener A, Denstedt JD, Pautler SE, Razvi H. KIM-1 is a potential urinary biomarker of obstruction: results from a prospective cohort study. J Endourol. 2017;31(2):111\u20138. https:\/\/doi.org\/10.1089\/end.2016.0215.","journal-title":"J Endourol"},{"issue":"6","key":"1098_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00345-018-2488-z","volume":"37","author":"S Qian","year":"2019","unstructured":"Qian S, Huang Y, Wang N, Ding Y, Qi J, Yu Y. Urinary neutrophil gelatinase-associated lipocalin as a biomarker to monitor renal function in patients with obstructive ureteral calculi. World J Urol. 2019;37(6):1197\u2013204. https:\/\/doi.org\/10.1007\/s00345-018-2488-z.","journal-title":"World J Urol"},{"key":"1098_CR11","doi-asserted-by":"publisher","unstructured":"\u2022 Sise ME, Forster C, Singer E, Sola-Del Valle D, Hahn B, Schmidt-Ott KM, Barasch J, Nickolas TL. Urine neutrophil gelatinase-associated lipocalin identifies unilateral and bilateral urinary tract obstruction. Nephrol Dial Transplant. 2011;26(12):4132\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfr569. Highlighted the real potential of NGAL as a biomarker in unilateral obstruction and its superiority compared to creatinine which showed no increase in unilateral obstruction in this study.","DOI":"10.1093\/ndt\/gfr569"},{"issue":"3","key":"1098_CR12","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/S1569-9056(17)30526-2","volume":"16","author":"F Talibzade","year":"2017","unstructured":"Talibzade F, Kaya C, Sahin B, Tanidir Y, Sekerci CA, Akbal C, Simsek F. Evaluation of urinary neutrophil gelatinase-associated lipocalin as a biomarker in pediatric and adult patients with ureteropelvic junction obstruction. Eur Urol Suppl. 2017;16(3):e804\u20135. https:\/\/doi.org\/10.1016\/S1569-9056(17)30526-2.","journal-title":"Eur Urol Suppl"},{"issue":"7","key":"1098_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/eci.12283","volume":"44","author":"A Urbschat","year":"2014","unstructured":"Urbschat A, Gauer S, Paulus P, Reissig M, Weipert C, Ramos-Lopez E, Hofmann R, Hadji P, Geiger H, Oberm\u00fcller N. Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI. Eur J Clin Invest. 2014;44(7):652\u20139. https:\/\/doi.org\/10.1111\/eci.12283.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1098_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/ijms20040899","volume":"20","author":"S Washino","year":"2019","unstructured":"Washino S, Hosohata K, Oshima M, Okochi T, Konishi T, Nakamura Y, Saito K, Miyagawa T. A novel biomarker for acute kidney injury, vanin-1, for obstructive nephropathy: a prospective cohort pilot study. Int J Mol Sci. 2019;20(4):899. https:\/\/doi.org\/10.3390\/ijms20040899.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1098_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112865","volume":"9","author":"Y Xie","year":"2014","unstructured":"Xie Y, Xue W, Shao X, Che X, Xu W, Ni Z, Mou S. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes. PLoS ONE. 2014;9(11): e112865. https:\/\/doi.org\/10.1371\/journal.pone.0112865.","journal-title":"PLoS ONE"},{"issue":"11","key":"1098_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrurol.2014.240","volume":"11","author":"F Khan","year":"2014","unstructured":"Khan F, Ahmed K, Lee N, Challacombe B, Khan MS, Dasgupta P. Management of ureteropelvic junction obstruction in adults. Nat Rev Urol. 2014;11(11):629\u201338. https:\/\/doi.org\/10.1038\/nrurol.2014.240.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"1098_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/2051415819872916","volume":"13","author":"D Moon","year":"2020","unstructured":"Moon D, Napier-Hemy T. Pelvic ureteric junction obstruction: Natural history, nephrological considerations and current evidence base for surgical management in poorer functioning kidneys. Journal of Clinical Urology. 2020;13(2):116\u201321. https:\/\/doi.org\/10.1177\/2051415819872916.","journal-title":"Journal of Clinical Urology"},{"key":"1098_CR18","unstructured":"Engelsgjerd JS, La Grange CA. Retroperitoneal fibrosis. In: StatPearls [Internet]. StatPearls Publishing. Treas Island (FL).\u00a02021."},{"key":"1098_CR19","unstructured":"\u2022 NGAL Human ELISA Kit. ThermoFisher Scientific. https:\/\/www.thermofisher.com\/elisa\/product\/BMS2202.html?ef_id. Accessed date November 9, 2021. Important to determine the cost and feasibility of NGAL testing in order to be utilised in healthcare practice."},{"issue":"4","key":"1098_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000364937","volume":"37","author":"J M\u00e5rtensson","year":"2014","unstructured":"M\u00e5rtensson J, Bellomo R. The rise and fall of NGAL in acute kidney injury. Blood Purif. 2014;37(4):304\u201310. https:\/\/doi.org\/10.1159\/000364937.","journal-title":"Blood Purif"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01098-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-022-01098-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-022-01098-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:05:32Z","timestamp":1656979532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-022-01098-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1007\/s11934-022-01098-6","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"2 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}